RSS

Pelago Bioscience

A two-year strategic research collaboration and licence agreement has been formed between Karolinska Institute spin out, Pelago Bioscience, and Vertex Pharmaceuticals that will focus on the CETSA method. more

News

Karolinska Institute spin out company, Pelago Bioscience, has entered into a strategic research collaboration and licence agreement with AstraZeneca for the further advancement of the CETSA method and its use in pre-clinical discovery more

News

Pelago Bioscience and AstraZeneca team up for cellular thermal shift assay (CETSA) more

News